Fisher & Paykel Healthcare Corporation akcijos akcijų analizė | Akcijų kaina | Naujienos | FPH.NZ | NZFAPE0001S2 | 881319

Data	Fisher & Paykel Healthcare Corporation Pajamos	Fisher & Paykel Healthcare Corporation EBIT	Fisher & Paykel Healthcare Corporation Pelnas
2027e	2,46 mlrd. NZD	673,92 mln. NZD	494,77 mln. NZD
2026e	2,21 mlrd. NZD	562,52 mln. NZD	414,29 mln. NZD
2025e	1,98 mlrd. NZD	467,55 mln. NZD	344,81 mln. NZD
2024	1,74 mlrd. NZD	353,40 mln. NZD	132,60 mln. NZD
2023	1,58 mlrd. NZD	332,20 mln. NZD	250,30 mln. NZD
2022	1,68 mlrd. NZD	505,60 mln. NZD	376,90 mln. NZD
2021	1,97 mlrd. NZD	712,30 mln. NZD	524,20 mln. NZD
2020	1,26 mlrd. NZD	379,30 mln. NZD	287,30 mln. NZD
2019	1,07 mlrd. NZD	292,60 mln. NZD	209,20 mln. NZD
2018	980,80 mln. NZD	269,80 mln. NZD	190,20 mln. NZD
2017	894,41 mln. NZD	240,12 mln. NZD	169,15 mln. NZD
2016	815,49 mln. NZD	211,08 mln. NZD	143,43 mln. NZD
2015	672,35 mln. NZD	170,08 mln. NZD	113,17 mln. NZD
2014	623,40 mln. NZD	143,50 mln. NZD	97,10 mln. NZD
2013	556,30 mln. NZD	112,70 mln. NZD	77,10 mln. NZD
2012	516,70 mln. NZD	92,80 mln. NZD	64,10 mln. NZD
2011	506,10 mln. NZD	97,70 mln. NZD	52,50 mln. NZD
2010	503,30 mln. NZD	99,60 mln. NZD	71,60 mln. NZD
2009	458,70 mln. NZD	102,40 mln. NZD	62,20 mln. NZD
2008	357,90 mln. NZD	58,10 mln. NZD	35,30 mln. NZD
2007	356,50 mln. NZD	89,60 mln. NZD	57,60 mln. NZD
2006	324,50 mln. NZD	104,10 mln. NZD	70,00 mln. NZD
2005	240,60 mln. NZD	89,70 mln. NZD	61,40 mln. NZD

	Pajamos	EBIT	Pelnas
2005	240,60 mln. NZD	89,70 mln. NZD	61,40 mln. NZD
2006	324,50 mln. NZD	104,10 mln. NZD	70,00 mln. NZD
2007	356,50 mln. NZD	89,60 mln. NZD	57,60 mln. NZD
2008	357,90 mln. NZD	58,10 mln. NZD	35,30 mln. NZD
2009	458,70 mln. NZD	102,40 mln. NZD	62,20 mln. NZD
2010	503,30 mln. NZD	99,60 mln. NZD	71,60 mln. NZD
2011	506,10 mln. NZD	97,70 mln. NZD	52,50 mln. NZD
2012	516,70 mln. NZD	92,80 mln. NZD	64,10 mln. NZD
2013	556,30 mln. NZD	112,70 mln. NZD	77,10 mln. NZD
2014	623,40 mln. NZD	143,50 mln. NZD	97,10 mln. NZD
2015	672,35 mln. NZD	170,08 mln. NZD	113,17 mln. NZD
2016	815,49 mln. NZD	211,08 mln. NZD	143,43 mln. NZD
2017	894,41 mln. NZD	240,12 mln. NZD	169,15 mln. NZD
2018	980,80 mln. NZD	269,80 mln. NZD	190,20 mln. NZD
2019	1,07 mlrd. NZD	292,60 mln. NZD	209,20 mln. NZD
2020	1,26 mlrd. NZD	379,30 mln. NZD	287,30 mln. NZD
2021	1,97 mlrd. NZD	712,30 mln. NZD	524,20 mln. NZD
2022	1,68 mlrd. NZD	505,60 mln. NZD	376,90 mln. NZD
2023	1,58 mlrd. NZD	332,20 mln. NZD	250,30 mln. NZD
2024	1,74 mlrd. NZD	353,40 mln. NZD	132,60 mln. NZD
2025e	1,98 mlrd. NZD	467,55 mln. NZD	344,81 mln. NZD
2026e	2,21 mlrd. NZD	562,52 mln. NZD	414,29 mln. NZD
2027e	2,46 mlrd. NZD	673,92 mln. NZD	494,77 mln. NZD

Fisher & Paykel Healthcare Corporation Bruto marža	Fisher & Paykel Healthcare Corporation Pelnas-martža	Fisher & Paykel Healthcare Corporation EBIT marža	Fisher & Paykel Healthcare Corporation Pelnas-martža
2027e	59,93 %	27,37 %	20,10 %
2026e	59,93 %	25,44 %	18,74 %
2025e	59,93 %	23,58 %	17,39 %
2024	59,93 %	20,28 %	7,61 %
2023	59,35 %	21,01 %	15,83 %
2022	62,60 %	30,06 %	22,41 %
2021	63,19 %	36,14 %	26,59 %
2020	66,14 %	30,02 %	22,73 %
2019	66,87 %	27,34 %	19,54 %
2018	66,31 %	27,51 %	19,39 %
2017	66,01 %	26,85 %	18,91 %
2016	63,97 %	25,88 %	17,59 %
2015	61,13 %	25,30 %	16,83 %
2014	58,61 %	23,02 %	15,58 %
2013	55,33 %	20,26 %	13,86 %
2012	53,22 %	17,96 %	12,41 %
2011	54,87 %	19,30 %	10,37 %
2010	53,92 %	19,79 %	14,23 %
2009	53,76 %	22,32 %	13,56 %
2008	50,32 %	16,23 %	9,86 %
2007	58,18 %	25,13 %	16,16 %
2006	59,93 %	32,08 %	21,57 %
2005	59,93 %	37,28 %	25,52 %

	Bruto marža	EBIT marža	Pelnas-martža
2005	59,93 %	37,28 %	25,52 %
2006	59,93 %	32,08 %	21,57 %
2007	58,18 %	25,13 %	16,16 %
2008	50,32 %	16,23 %	9,86 %
2009	53,76 %	22,32 %	13,56 %
2010	53,92 %	19,79 %	14,23 %
2011	54,87 %	19,30 %	10,37 %
2012	53,22 %	17,96 %	12,41 %
2013	55,33 %	20,26 %	13,86 %
2014	58,61 %	23,02 %	15,58 %
2015	61,13 %	25,30 %	16,83 %
2016	63,97 %	25,88 %	17,59 %
2017	66,01 %	26,85 %	18,91 %
2018	66,31 %	27,51 %	19,39 %
2019	66,87 %	27,34 %	19,54 %
2020	66,14 %	30,02 %	22,73 %
2021	63,19 %	36,14 %	26,59 %
2022	62,60 %	30,06 %	22,41 %
2023	59,35 %	21,01 %	15,83 %
2024	59,93 %	20,28 %	7,61 %
2025e	59,93 %	23,58 %	17,39 %
2026e	59,93 %	25,44 %	18,74 %
2027e	59,93 %	27,37 %	20,10 %

Data	Fisher & Paykel Healthcare Corporation Pardavimai vienai akcijai	Fisher & Paykel Healthcare Corporation EBIT vienai akcijai	Fisher & Paykel Healthcare Corporation Pelnas vienai akcijai
2027e	4,20 NZD	0 NZD	0,84 NZD
2026e	3,77 NZD	0 NZD	0,71 NZD
2025e	3,39 NZD	0 NZD	0,59 NZD
2024	2,97 NZD	0,60 NZD	0,23 NZD
2023	2,72 NZD	0,57 NZD	0,43 NZD
2022	2,90 NZD	0,87 NZD	0,65 NZD
2021	3,40 NZD	1,23 NZD	0,90 NZD
2020	2,18 NZD	0,66 NZD	0,50 NZD
2019	1,85 NZD	0,51 NZD	0,36 NZD
2018	1,71 NZD	0,47 NZD	0,33 NZD
2017	1,56 NZD	0,42 NZD	0,29 NZD
2016	1,43 NZD	0,37 NZD	0,25 NZD
2015	1,18 NZD	0,30 NZD	0,20 NZD
2014	1,12 NZD	0,26 NZD	0,17 NZD
2013	0,99 NZD	0,20 NZD	0,14 NZD
2012	0,96 NZD	0,17 NZD	0,12 NZD
2011	0,94 NZD	0,18 NZD	0,10 NZD
2010	0,95 NZD	0,19 NZD	0,14 NZD
2009	0,87 NZD	0,19 NZD	0,12 NZD
2008	0,68 NZD	0,11 NZD	0,07 NZD
2007	0,68 NZD	0,17 NZD	0,11 NZD
2006	0,62 NZD	0,20 NZD	0,13 NZD
2005	0,46 NZD	0,17 NZD	0,12 NZD

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2005	0,46 NZD	0,17 NZD	0,12 NZD
2006	0,62 NZD	0,20 NZD	0,13 NZD
2007	0,68 NZD	0,17 NZD	0,11 NZD
2008	0,68 NZD	0,11 NZD	0,07 NZD
2009	0,87 NZD	0,19 NZD	0,12 NZD
2010	0,95 NZD	0,19 NZD	0,14 NZD
2011	0,94 NZD	0,18 NZD	0,10 NZD
2012	0,96 NZD	0,17 NZD	0,12 NZD
2013	0,99 NZD	0,20 NZD	0,14 NZD
2014	1,12 NZD	0,26 NZD	0,17 NZD
2015	1,18 NZD	0,30 NZD	0,20 NZD
2016	1,43 NZD	0,37 NZD	0,25 NZD
2017	1,56 NZD	0,42 NZD	0,29 NZD
2018	1,71 NZD	0,47 NZD	0,33 NZD
2019	1,85 NZD	0,51 NZD	0,36 NZD
2020	2,18 NZD	0,66 NZD	0,50 NZD
2021	3,40 NZD	1,23 NZD	0,90 NZD
2022	2,90 NZD	0,87 NZD	0,65 NZD
2023	2,72 NZD	0,57 NZD	0,43 NZD
2024	2,97 NZD	0,60 NZD	0,23 NZD
2025e	3,39 NZD	0 NZD	0,59 NZD
2026e	3,77 NZD	0 NZD	0,71 NZD
2027e	4,20 NZD	0 NZD	0,84 NZD

	Akcijų skaičius
2005	523,80 mln. Aktien
2006	524,80 mln. Aktien
2007	524,80 mln. Aktien
2008	524,90 mln. Aktien
2009	527,40 mln. Aktien
2010	529,80 mln. Aktien
2011	536,30 mln. Aktien
2012	536,30 mln. Aktien
2013	559,10 mln. Aktien
2014	557,80 mln. Aktien
2015	569,55 mln. Aktien
2016	572,04 mln. Aktien
2017	574,34 mln. Aktien
2018	574,34 mln. Aktien
2019	578,05 mln. Aktien
2020	579,05 mln. Aktien
2021	579,59 mln. Aktien
2022	579,99 mln. Aktien
2023	581,63 mln. Aktien
2024	586,18 mln. Aktien
2025e	586,18 mln. Aktien
2026e	586,18 mln. Aktien
2027e	586,18 mln. Aktien

Data	Fisher & Paykel Healthcare Corporation Dividendas
2027e	0,40 NZD
2026e	0,40 NZD
2025e	0,39 NZD
2024	0,37 NZD
2023	0,64 NZD
2022	0,63 NZD
2021	0,34 NZD
2020	0,06 NZD
2019	0,19 NZD
2018	0,31 NZD
2017	0,14 NZD
2016	0,13 NZD
2015	0,11 NZD
2014	0,18 NZD
2013	0,02 NZD
2012	0,02 NZD
2011	0,17 NZD
2010	0,18 NZD
2009	0,18 NZD
2008	0,19 NZD
2007	0,19 NZD
2006	0,19 NZD
2005	0,17 NZD

	Dividendas	Dividenda (įvertinimas)
2005	0,17 NZD	0 NZD
2006	0,19 NZD	0 NZD
2007	0,19 NZD	0 NZD
2008	0,19 NZD	0 NZD
2009	0,18 NZD	0 NZD
2010	0,18 NZD	0 NZD
2011	0,17 NZD	0 NZD
2012	0,02 NZD	0 NZD
2013	0,02 NZD	0 NZD
2014	0,18 NZD	0 NZD
2015	0,11 NZD	0 NZD
2016	0,13 NZD	0 NZD
2017	0,14 NZD	0 NZD
2018	0,31 NZD	0 NZD
2019	0,19 NZD	0 NZD
2020	0,06 NZD	0 NZD
2021	0,34 NZD	0 NZD
2022	0,63 NZD	0 NZD
2023	0,64 NZD	0 NZD
2024	0,37 NZD	0 NZD
2025e	0 NZD	0,39 NZD
2026e	0 NZD	0,40 NZD
2027e	0 NZD	0,40 NZD

Data	Fisher & Paykel Healthcare Corporation Išmokėjimo santykis
2027e	62,66 %
2026e	59,05 %
2025e	68,38 %
2024	60,56 %
2023	48,22 %
2022	96,35 %
2021	37,10 %
2020	11,20 %
2019	52,63 %
2018	93,64 %
2017	48,00 %
2016	52,74 %
2015	53,93 %
2014	104,58 %
2013	15,63 %
2012	18,24 %
2011	172,22 %
2010	126,53 %
2009	147,62 %
2008	264,39 %
2007	168,25 %
2006	142,37 %
2005	139,30 %

	Išmokėjimo santykis
2005	139,30 %
2006	142,37 %
2007	168,25 %
2008	264,39 %
2009	147,62 %
2010	126,53 %
2011	172,22 %
2012	18,24 %
2013	15,63 %
2014	104,58 %
2015	53,93 %
2016	52,74 %
2017	48,00 %
2018	93,64 %
2019	52,63 %
2020	11,20 %
2021	37,10 %
2022	96,35 %
2023	48,22 %
2024	60,56 %
2025e	68,38 %
2026e	59,05 %
2027e	62,66 %

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2024-03-31	0,25 NZD	0,27 NZD (5,74 %)	2024 Q4
2023-09-30	0,18 NZD	0,18 NZD (−0,16 %)	2024 Q2
2023-03-31	0,24 NZD	0,27 NZD (11,63 %)	2023 Q4
2022-09-30	0,17 NZD	0,17 NZD (−3,90 %)	2023 Q2
2022-03-31	0,26 NZD	0,27 NZD (1,68 %)	2022 Q4
2021-09-30	0,30 NZD	0,38 NZD (26,40 %)	2022 Q2
2021-03-31	0,60 NZD	0,52 NZD (−13,58 %)	2021 Q4
2020-09-30	0,35 NZD	0,39 NZD (10,04 %)	2021 Q2
2020-03-31	0,27 NZD	0,29 NZD (5,24 %)	2020 Q4
2019-09-30	0,21 NZD	0,21 NZD (−1,46 %)	2020 Q2
2019-03-31	0,19 NZD	0,19 NZD (0,57 %)	2019 Q4
2016-03-31	0,14 NZD	0,14 NZD (−0,99 %)	2016 Q4

%	Pavadinimas	Akcijos	Pokytis	Data
8,22 %	Mitsubishi UFJ Financial Group Inc	48 116 648	6 263 918	2023-08-31
6,16 %	Pinnacle Investment Management Group Ltd	36 059 206	6 695 516	2023-10-10
6,05 %	Hyperion Asset Management Limited	35 452 466	6 068 277	2023-10-10
3,39 %	BlackRock Institutional Trust Company, N.A.	19 861 904	0	2023-03-31
3,03 %	The Vanguard Group, Inc.	17 724 598	−20 986	2024-03-31
2,48 %	Stewart Investors	14 541 902	1 716 954	2023-09-30
1,64 %	Norges Bank Investment Management (NBIM)	9 579 196	628 315	2023-12-31
1,56 %	Accident Compensation Corporation	9 144 701	−1 146 159	2023-03-31
1,54 %	First Sentier Investors (Hong Kong) Limited	8 993 877	−608 792	2023-12-31
1,05 %	BlackRock Investment Management (Australia) Ltd.	6 124 607	0	2023-03-31
0,95 %	BlackRock Investment Management (UK) Ltd.	5 536 599	0	2023-03-31
0,81 %	Public Trust	4 724 236	4 724 236	2023-03-31
0,66 %	Geode Capital Management, L.L.C.	3 878 337	410	2024-03-31
0,54 %	BlackRock Advisors (UK) Limited	3 162 973	0	2023-03-31
0,48 %	Bennelong Australian Equity Partners Pty. Ltd.	2 825 082	0	2023-12-31
0,48 %	Vanguard Investments Australia Ltd.	2 783 612	−641	2024-02-29
0,43 %	Capital Research Global Investors	2 510 000	0	2024-03-31
0,38 %	First Sentier Investments (U.K.) Ltd	2 196 821	0	2023-09-30
0,28 %	Charles Schwab Investment Management, Inc.	1 612 358	15 753	2024-03-31
0,27 %	Columbia Wanger Asset Management, LLC	1 575 160	0	2024-02-29
0,26 %	JP Morgan Asset Management	1 511 120	8 245	2024-03-31
0,25 %	Invesco Advisers, Inc.	1 458 382	0	2024-02-29
0,24 %	FIL Investment Management (Australia) Limited	1 376 689	95 691	2024-02-29
0,23 %	Australian Ethical Investment Ltd.	1 344 518	1 344 518	2022-12-31
0,22 %	WHEB Asset Management LLP	1 292 185	−333 972	2024-02-29
0,22 %	T. Rowe Price International Ltd	1 289 745	1 286	2024-03-31
0,21 %	MLC Asset Management	1 225 028	−23 259	2023-12-31
0,20 %	Dimensional Fund Advisors, L.P.	1 144 333	−3 220	2024-03-31
0,19 %	BetaShares Capital Ltd.	1 089 893	11 049	2024-03-31
0,18 %	State Street Global Advisors (US)	1 027 960	−368	2024-03-31
0,17 %	State Street Global Advisors (UK) Ltd.	1 019 283	0	2024-03-31
0,16 %	Nuveen LLC	934 900	0	2024-03-31
0,15 %	Daniell (Michael Grenfell)	900 168	0	2023-03-31
0,15 %	Veritas Asset Management LLP	900 000	0	2024-02-29
0,15 %	Victory Capital Management Inc.	870 423	56 177	2023-12-31
0,14 %	California State Teachers Retirement System	829 110	−115 733	2023-06-30
0,14 %	BlackRock Investment Management, LLC	804 201	0	2023-03-31
0,13 %	Storebrand Kapitalforvaltning AS	762 341	−4 525	2024-02-29
0,13 %	Legal & General Investment Management Ltd.	751 900	0	2024-03-31
0,12 %	BlackRock Financial Management, Inc.	722 442	0	2023-03-31
0,12 %	Aviva Investors Global Services Limited	717 100	3 201	2024-03-31
0,12 %	BlackRock Asset Management Canada Limited	711 969	0	2023-03-31
0,11 %	Achmea Investment Management B.V.	658 282	−443	2024-02-29
0,10 %	Wellington Management Company, LLP	611 331	2 884	2024-02-29
0,10 %	HSBC Global Asset Management (UK) Limited	601 539	15 234	2024-02-29
0,10 %	Gradon (Lewis George)	578 556	96	2023-10-27
0,07 %	AEGON Investment Management B.V.	431 873	5 852	2023-12-31
0,07 %	BlackRock Japan Co., Ltd.	430 518	0	2023-03-31
0,07 %	APG Asset Management N.V.	410 293	−189 411	2023-09-30
0,07 %	Shearer (Paul Nigel)	399 342	96	2023-10-27
0,07 %	Caisse de Depot et Placement du Quebec	398 209	−955 347	2022-12-31
0,07 %	Credit Suisse Funds AG	393 409	5 391	2024-03-31
0,06 %	Northern Trust Global Investments Limited	342 357	6 410	2023-12-31
0,06 %	State Street Global Advisors Australia Ltd.	334 654	−984	2024-03-31
0,05 %	UBS Asset Management (Switzerland)	303 075	0	2024-02-29
0,05 %	DWS Investments UK Limited	290 719	−1 164	2024-03-31
0,05 %	Dundas Global Investors	270 866	0	2023-12-31
0,05 %	Goldman Sachs Asset Management, L.P.	266 309	362	2024-03-31
0,05 %	State Street Global Advisors Ireland Limited	265 515	2 226	2024-03-31
0,04 %	DWS Investment GmbH	255 780	7 876	2024-03-31
0,04 %	Royal London Asset Management Ltd.	255 707	248	2023-12-31
0,04 %	MLC Investments Limited	242 648	16 524	2023-12-31
0,04 %	Vanguard Global Advisers LLC	235 072	14 113	2024-03-31
0,04 %	PGGM Vermogensbeheer B.V.	213 109	−29 631	2023-07-31
0,04 %	Mellon Investments Corporation	212 261	−47 086	2024-03-31
0,04 %	Amundi Asset Management, SAS	211 084	5 552	2024-03-31
0,04 %	VanEck Australia Pty Ltd.	207 976	17 555	2023-12-31
0,04 %	MFS Investment Management	205 370	−995	2024-02-29
0,03 %	BlackRock International Ltd.	203 022	0	2023-03-31
0,03 %	Pendal Group Limited	202 213	−78 751	2023-12-31
0,03 %	DBX Advisors LLC.	199 145	14 623	2024-02-29
0,03 %	Handelsbanken Kapitalförvaltning AB	191 993	0	2024-03-31
0,03 %	Harbour Asset Management Limited	190 080	−5 092	2023-12-31
0,03 %	Van Eck Associates Corporation	172 252	1 048	2023-03-31
0,03 %	BMO Asset Management Inc.	171 685	0	2024-03-31
0,03 %	Mackenzie Financial Corporation	170 182	−1 006	2024-03-31
0,03 %	Manulife Investment Management (North America) Limited	169 996	−11 002	2024-01-31
0,03 %	Cardano Asset Management NV	168 115	−2 239	2024-02-29
0,03 %	Northern Trust Investments, Inc.	165 565	−822	2024-03-31
0,03 %	TD Asset Management Inc.	158 147	510	2024-03-31
0,02 %	Bellevue Asset Management AG	144 993	−58 907	2024-02-29
0,02 %	Zürcher Kantonalbank (Asset Management)	141 327	0	2024-02-29
0,02 %	UBS Asset Management (UK) Ltd.	138 456	−109	2024-03-31
0,02 %	AllianceBernstein L.P.	131 588	−5 358	2024-02-29
0,02 %	Pictet Asset Management Ltd.	126 693	724	2023-12-31
0,02 %	Aperio Group, LLC	126 055	0	2023-03-31
0,02 %	OP Varainhoito Oy	125 402	11 387	2024-02-29
0,02 %	Principal Global Investors (Equity)	120 045	−370	2024-02-29
0,02 %	Goodbody Asset Management	118 450	118 450	2023-06-30
0,02 %	First Sentier Investors (Singapore)	112 241	−13 468	2023-12-31
0,02 %	KLP Fondsforvaltning AS	109 388	0	2024-02-29
0,02 %	SunAmerica Asset Management, LLC	107 757	292	2024-02-29
0,02 %	Deka Investment GmbH	106 520	208	2024-03-31
0,02 %	Somervell (Andrew Robert Donald)	103 538	48	2023-10-27
0,02 %	Florida State Board of Administration	102 953	−742 420	2022-09-30
0,02 %	abrdn Investments Limited	97 452	6 750	2024-02-29
0,02 %	JPMorgan Asset Management U.K. Limited	96 824	−3 326	2024-03-31
0,02 %	Triodos Investment Management BV	95 000	0	2024-02-29
0,02 %	Danske Bank Asset Management	92 520	0	2024-03-31
0,02 %	Debeka Asset Management GmbH	90 800	0	2024-01-31

What values and corporate philosophy does Fisher & Paykel Healthcare Corporation represent?

Fisher & Paykel Healthcare Corporation Ltd represents values of innovation, excellence, and care. As a leading healthcare solutions provider, the company prioritizes delivering superior products and improving patient outcomes. Fisher & Paykel Healthcare Corporation is committed to developing advanced respiratory care devices and technologies that offer increased comfort and efficiency. With a focus on user-centric design, the company strives to enhance the quality of life for patients worldwide. By integrating cutting-edge technology and compassionate care, Fisher & Paykel Healthcare Corporation is dedicated to positively impacting the healthcare industry, while continuously nurturing a culture of innovation and integrity.

In which countries and regions is Fisher & Paykel Healthcare Corporation primarily present?

Fisher & Paykel Healthcare Corporation Ltd is primarily present in several countries and regions worldwide. The company has a strong presence in North America, including the United States and Canada, where it has established significant operations. Additionally, Fisher & Paykel Healthcare Corporation Ltd has a substantial presence in Europe, with a focus on countries like Germany, France, and the United Kingdom. The company also operates in the Asia-Pacific region, specifically targeting countries such as Australia and New Zealand. Furthermore, Fisher & Paykel Healthcare Corporation Ltd has expanded its reach to other key markets, including Japan and parts of Latin America.

What significant milestones has the company Fisher & Paykel Healthcare Corporation achieved?

Fisher & Paykel Healthcare Corporation Ltd has achieved several significant milestones over the years. The company introduced the first heated humidifier for respiratory patients in 1989, revolutionizing patient care. In 2001, Fisher & Paykel Healthcare launched its innovative Optiflow nasal high flow therapy, providing a more comfortable and effective respiratory support system. The company also expanded its global presence, establishing a distribution center in Mexico in 2004 and acquiring Healthcare Technologies in 2018 to enhance its sleep apnea product offerings. Furthermore, Fisher & Paykel Healthcare received numerous awards and recognitions for its commitment to innovation, quality, and improving patient outcomes.

What is the history and background of the company Fisher & Paykel Healthcare Corporation?

Fisher & Paykel Healthcare Corporation Ltd is a renowned company that specializes in manufacturing medical devices and equipment. Established in 1934 in New Zealand, the company has a rich history and strong background in the healthcare industry. Fisher & Paykel Healthcare Corporation Ltd has grown to become a global leader in providing innovative solutions for respiratory care, sleep apnea treatment, and acute care. With a focus on research and development, the company has continually introduced cutting-edge technologies and products, earning a reputation for delivering high-quality and reliable medical devices. Fisher & Paykel Healthcare Corporation Ltd's dedication to improving patient care has made it a trusted and recognized name in the healthcare sector worldwide.

Who are the main competitors of Fisher & Paykel Healthcare Corporation in the market?

Fisher & Paykel Healthcare Corporation Ltd faces competition from several key players in the market. Some of its main competitors include ResMed Inc., which specializes in the development and manufacturing of medical equipment and devices for sleep apnea and other respiratory disorders, and Philips Respironics, a leading global healthcare company that offers respiratory and sleep solutions. Additionally, Medtronic plc, a multinational medical technology company, is also a notable competitor in the market. These companies strive to provide innovative healthcare solutions to patients worldwide, similar to Fisher & Paykel Healthcare Corporation Ltd.

In which industries is Fisher & Paykel Healthcare Corporation primarily active?

Fisher & Paykel Healthcare Corporation Ltd is primarily active in the healthcare industry.

What is the business model of Fisher & Paykel Healthcare Corporation?

The business model of Fisher & Paykel Healthcare Corporation Ltd is focused on designing, manufacturing, and marketing a range of medical devices and systems for use in respiratory care, acute care, and surgery. The company specializes in innovative solutions such as nasal high flow therapy, humidification systems, and sleep apnea devices. Fisher & Paykel Healthcare Corporation aims to improve patient outcomes and enhance the quality of care offered by healthcare professionals. With a strong commitment to research and development, the company consistently introduces cutting-edge technologies and strives to provide effective and efficient medical products and services. Fisher & Paykel Healthcare Corporation Ltd stands as a leading player in the global healthcare industry.

Koks yra Fisher & Paykel Healthcare Corporation 2024 KGV?

Fisher & Paykel Healthcare Corporation KGV yra 135,94.

Koks Fisher & Paykel Healthcare Corporation 2024 KUV?

Fisher & Paykel Healthcare Corporation KUV yra 10,34.

Koks yra Fisher & Paykel Healthcare Corporation AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Fisher & Paykel Healthcare Corporation yra 6/10.

Koks yra Fisher & Paykel Healthcare Corporation 2024 pajamų dydis?

Fisher & Paykel Healthcare Corporation pardavimai yra 1,74 mlrd. NZD.

Kokia yra Fisher & Paykel Healthcare Corporation 2024 pelnas?

Fisher & Paykel Healthcare Corporation pelnas yra 132,60 mln. NZD.

Ką daro Fisher & Paykel Healthcare Corporation?

Fisher & Paykel Healthcare Corporation Ltd is an internationally known company that manufactures medical devices for ventilation, oxygen therapy, and the clinical sleep area. The company's business model is based on offering high-quality and innovative products at a reasonable price to improve its customers' quality of life.

Kokia yra Fisher & Paykel Healthcare Corporation dividendė?

Fisher & Paykel Healthcare Corporation moka dividendą 0,63 NZD, kuris yra paskirstytas per 2 išmokas per metus.

Kiek kartų Fisher & Paykel Healthcare Corporation moka dividendą?

„Fisher & Paykel Healthcare Corporation moka dividendus 2 kartus per metus.“

Kas yra Fisher & Paykel Healthcare Corporation ISIN?

Fisher & Paykel Healthcare Corporation ISIN yra NZFAPE0001S2.

Kas yra Fisher & Paykel Healthcare Corporation WKN?

Fisher & Paykel Healthcare Corporation WKN yra 881319.

Kas yra Fisher & Paykel Healthcare Corporation Tickeris?

Fisher & Paykel Healthcare Corporation akcijų simbolis yra FPH.NZ.

Kiek dividendų moka Fisher & Paykel Healthcare Corporation?

Per paskutinius 12 mėnesių Fisher & Paykel Healthcare Corporation išmokėjo dividendą, kurios dydis siekė 0,37 NZD . Tai atitinka maždaug 1,20 % dividendų grąžą. Artimiausiems 12 mėnesiams Fisher & Paykel Healthcare Corporation tikėtina išmokės dividendus, kurie sudarys 0,39 NZD.

Kokia yra Fisher & Paykel Healthcare Corporation dividendų grąža?

Fisher & Paykel Healthcare Corporation šiuo metu yra 1,20 % dydžio dividendų grąža.

Kada Fisher & Paykel Healthcare Corporation moka dividendus?

Fisher & Paykel Healthcare Corporation moka dividendus kas ketvirtį. Jie išmokami sausis, liepa, sausis, liepa mėnesiais.

Kokia saugi yra Fisher & Paykel Healthcare Corporation dividendų išmokėjimas?

Fisher & Paykel Healthcare Corporation per paskutiniuosius 23 metus kiekvienais metais mokėjo dividendus.

Kokia yra Fisher & Paykel Healthcare Corporation dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0,39 NZD. Tai atitinka 1,28 % dividendų grąžos procentą.

Kokiame sektoriuje yra Fisher & Paykel Healthcare Corporation?

Fisher & Paykel Healthcare Corporation priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Fisher & Paykel Healthcare Corporation kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Fisher & Paykel Healthcare Corporation dividendą nuo 2024-07-10, kurio dydis yra 0,368 NZD, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-06-26.

Kada Fisher & Paykel Healthcare Corporation paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-07-10.

Kokia buvo Fisher & Paykel Healthcare Corporation dividendų suma 2023 metais?

2023 metais Fisher & Paykel Healthcare Corporation išmokėjo 0,642 NZD dividendų.

Kokia valiuta Fisher & Paykel Healthcare Corporation moka dividendus?

Fisher & Paykel Healthcare Corporation dividendai yra mokami NZD.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
0,68	0,80	0,92	0,21	0,21	0,21	0,24	0,32	0,36	0,36	0,46	0,50	0,51	0,52	0,56	0,62	0,67	0,82	0,89	0,98	1,07	1,26	1,97	1,68	1,58	1,74	1,98	2,21	2,46
-	17,40	14,94	−76,81	−2,80	2,88	12,15	35,00	9,88	0,28	28,29	9,83	0,60	1,98	7,75	12,05	7,87	21,28	9,69	9,62	9,18	18,04	56,06	−14,71	−5,95	10,18	13,83	11,50	11,35
-	-	-	-	-	-	-	-	58,15	50,42	53,71	53,88	54,74	53,29	55,22	58,59	61,01	63,93	66,00	66,33	66,82	66,11	63,17	62,58	59,33	59,93	-	-	-
0	0	0	0	0	0	0	0	0,21	0,18	0,25	0,27	0,28	0,28	0,31	0,37	0,41	0,52	0,59	0,65	0,72	0,84	1,25	1,05	0,94	1,04	0	0	0
61,00	92,00	130,00	81,00	73,00	79,00	89,00	104,00	89,00	58,00	102,00	99,00	97,00	92,00	112,00	143,00	170,00	211,00	240,00	269,00	292,00	379,00	712,00	505,00	332,00	353,00	467,00	562,00	673,00
8,92	11,46	14,08	37,85	35,10	36,92	37,08	32,10	25,00	16,25	22,27	19,68	19,17	17,83	20,14	22,95	25,30	25,89	26,85	27,45	27,29	30,01	36,12	30,04	21,00	20,26	23,55	25,42	27,34
18,00	54,00	11,00	48,00	72,00	54,00	61,00	70,00	57,00	35,00	62,00	71,00	52,00	64,00	77,00	97,00	113,00	143,00	169,00	190,00	209,00	287,00	524,00	376,00	250,00	132,00	344,00	414,00	494,00
-	200,00	−79,63	336,36	50,00	−25,00	12,96	14,75	−18,57	−38,60	77,14	14,52	−26,76	23,08	20,31	25,97	16,49	26,55	18,18	12,43	10,00	37,32	82,58	−28,24	−33,51	−47,20	160,61	20,35	19,32
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
587,70	588,20	590,60	560,90	519,80	524,10	523,80	524,80	524,80	524,90	527,40	529,80	536,30	536,30	559,10	557,80	569,55	572,04	574,34	574,34	578,05	579,05	579,59	579,99	581,63	586,18	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	376,00	250,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	86,00	93,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−6,00	4,00
40,00	40,00	43,00	33,00	3,00	2,00	1,00	1,00	0	0	1,00	35,00	0	24,00	0	0	4,00	5,00	5,00	6,00	8,00	4,00	1,00	2,00	2,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−107,00	−41,00
−25,00	−23,00	−28,00	−1,00	0	0	0	0	−2,00	−5,00	−9,00	−6,00	−6,00	−4,00	−4,00	−7,00	−5,00	−5,00	−6,00	−2,00	−4,00	−5,00	−4,00	−4,00	−9,00
−10,00	−15,00	−14,00	−24,00	−40,00	−24,00	−29,00	−26,00	−25,00	−15,00	−22,00	−23,00	−25,00	−24,00	−25,00	−27,00	−44,00	−63,00	−74,00	−69,00	−81,00	−93,00	−131,00	−249,00	−121,00
61,00	87,00	105,00	67,00	46,00	60,00	72,00	96,00	56,00	44,00	62,00	137,00	71,00	93,00	86,00	104,00	146,00	144,00	193,00	247,00	253,00	321,00	625,00	324,00	238,00
−60,00	−65,00	−48,00	−13,00	−16,00	−8,00	−16,00	−52,00	−27,00	−13,00	−22,00	−48,00	−43,00	−67,00	−62,00	−31,00	−53,00	−65,00	−62,00	−98,00	−133,00	−170,00	−184,00	−169,00	−211,00
−57,00	−94,00	−45,00	280,00	−51,00	8,00	−13,00	−51,00	−16,00	−13,00	−22,00	−48,00	−43,00	−67,00	−62,00	−31,00	−53,00	−65,00	−62,00	−198,00	−125,00	−155,00	−387,00	−89,00	−11,00
3,00	−29,00	3,00	293,00	−34,00	16,00	3,00	0	10,00	0	0	0	0	0	0	0	0	0	0	−99,00	7,00	15,00	−202,00	80,00	200,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
38,00	52,00	−29,00	0	−5,00	0	0	15,00	19,00	42,00	28,00	−29,00	7,00	21,00	18,00	−22,00	−45,00	−8,00	0	21,00	0	−14,00	−10,00	−14,00	−4,00
0	0	0	−185,00	0	−2,00	−7,00	−4,00	0	−11,00	0	7,00	23,00	23,00	26,00	27,00	1,00	0	0	0	0	0	0	0	0
0	−7,00	−42,00	−277,00	−54,00	−56,00	−65,00	−50,00	−48,00	−35,00	−37,00	−90,00	−37,00	−24,00	−26,00	−66,00	−90,00	−74,00	−87,00	−79,00	−113,00	−159,00	−188,00	−235,00	−197,00
3,00	2,00	2,00	−12,00	3,00	2,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,00	2,00	3,00	3,00	3,00
−41,00	−61,00	−14,00	−79,00	−52,00	−56,00	−58,00	−62,00	−68,00	−68,00	−66,00	−68,00	−68,00	−70,00	−71,00	−72,00	−47,00	−68,00	−89,00	−102,00	−114,00	−146,00	−181,00	−224,00	−195,00
61,00	72,00	120,00	131,00	23,00	95,00	93,00	117,00	74,00	59,00	96,00	130,00	92,00	100,00	115,00	145,00	195,00	2,00	313,00	283,00	346,00	421,00	809,00	575,00	397,00
1,10	22,30	56,60	54,60	29,50	51,80	55,30	44,00	28,70	30,90	39,70	89,10	27,80	26,40	24,40	72,20	93,25	78,81	130,59	149,10	120,00	150,70	440,60	154,50	26,90
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Tiesioginiai išleidimai	1 776,86
Netiesioginės emisijos iš įsigytos energijos	13 341,68
Tiesioginiai išmetimai iš vertybių grandinės	457 112,75
CO₂ emisijos	15 118,54
CO₂ mažinimo strategija	✅
Anglies energija	❌
Atomkraft	❌
Bandymai su gyvūnais	✅
Pelz & Leder	—
Pesticidai	—
Palmių aliejus	—
Tabakas	❌
Genetinė inžinerija	❌
Klimato koncepcija	—
Tvarioji miškininkystė	—
Perdirbimo nuostatai	✅
Aplinkai draugiška pakuotė	✅
Pavojingosios medžiagos	✅
Degalų sąnaudos ir efektyvumas	❌
Vandens suvartojimas ir efektyvumas	✅

Moterų dalis tarp darbuotojų	54,755
Moterų dalis valdyme	—
Azijietiškų darbuotojų dalis	—
Akcijų dalis Azijos valdyme	—
Hispanų/lotynų kilmės darbuotojų dalis	—
Hispanų/latino kilmės vadybos dalis	—
Akcijų turimų tamsios odos darbuotojų procentas	—
Juodaodžių valdymo dalis	—
Baltųjų darbuotojų dalis	—
Baltųjų valdymo dalis	—
Suaugusiųjų turinys	❌
Alkoholis	❌
Ginkluotė	—
Šaunamieji ginklai	❌
Azartiniai lošimai	❌
Karinių sutarčių	❌
Žmogaus teisių koncepcija	✅
Privatumo politika	—
Darbo ir sveikatos apsauga	✅
Katalikiškas	✅

Tvarumo ataskaita	✅
Akcijų turėtojų įtraukimas	✅
Atsiliepimo taisyklės	❌
Kartelio teisė	❌

Birža	Fisher & Paykel Healthcare Corporation Akcijų kodas
ASX	FPH.AX
FRANKFURTAS	FPLB.F
MIUNCHENAS	FPLB.MU
NZW	FPH.NZ
PNK	FSPKF

Fisher & Paykel Healthcare Corporation Akcijų kodas	Fisher & Paykel Healthcare Corporation FIGI
FPH:AU	BBG000CLWTV6
FPH:AT	BBG000CLWVG8
FPLB:GR	BBG000CPR0R1
FPLB:GF	BBG000CPR171
FPLB:GS	BBG000CPR2Z8
FPLB:GM	BBG000CPR3L1
FPLB:GB	BBG000CPR3V0
FPH:NZ	BBG000D2JJS8
FSPKF:US	BBG000D35BD4
FSPKF:PQ	BBG000D35J01
FSPKF:UV	BBG000D35KF2
FPH:AH	BBG002F3JMX7
FPHNZD:X2	BBG00JRSXQY6
FPHNZD:XB	BBG00JRSXQZ5
FPHNZD:XH	BBG00JRSXR10
FPHNZD:XF	BBG00JRSXR38
FPHNZD:XE	BBG00JRSXR56
FPHNZD:XJ	BBG00JRSXR65
FPHNZD:XL	BBG00JRSXR74
FPHNZD:XG	BBG00JRSXR83
FPHNZD:XO	BBG00JRSXR92
FPHNZD:XS	BBG00JRSXRF5
FPHNZD:XA	BBG00JRSXRG4
FPHNZD:E1	BBG00JRSXRH3
FPHNZD:XT	BBG00JRSXRJ1
FPHNZD:XW	BBG00JRSXRK9
FPHNZD:XU	BBG00JRSXRL8
FPHNZD:XV	BBG00JRSXRM7
FPHNZD:XM	BBG00JRSXRN6
FPHNZD:XQ	BBG00JRSXRQ3
FPHNZD:XX	BBG00JRSXRR2
FPHNZD:XZ	BBG00JRSXRS1
FPHNZD:EU	BBG00JRSXRV7
FPHAUD:X2	BBG00JZ5MNZ5
FPHAUD:XB	BBG00JZ5MP08
FPHAUD:XH	BBG00JZ5MP26
FPHAUD:XF	BBG00JZ5MP44
FPHAUD:XE	BBG00JZ5MP62
FPHAUD:XJ	BBG00JZ5MP71
FPHAUD:XL	BBG00JZ5MP80
FPHAUD:XG	BBG00JZ5MP99
FPHAUD:XO	BBG00JZ5MPB6
FPHAUD:XS	BBG00JZ5MPG1
FPHAUD:XA	BBG00JZ5MPH0
FPHAUD:E1	BBG00JZ5MPJ8
FPHAUD:XT	BBG00JZ5MPK6
FPHAUD:XW	BBG00JZ5MPL5
FPHAUD:XU	BBG00JZ5MPM4
FPHAUD:XV	BBG00JZ5MPN3
FPHAUD:XM	BBG00JZ5MPP1
FPHAUD:XQ	BBG00JZ5MPR9
FPHAUD:XX	BBG00JZ5MPS8
FPHAUD:XZ	BBG00JZ5MPT7
FPHAUD:EU	BBG00JZ5MPW3
FPHNZD:EP	BBG00QZ27494
FPHNZD:EZ	BBG00QZ274C0
FPLB:GZ	BBG00TTCL1F6
FPH1EUR:EP	BBG00TTG2T21
FPH1EUR:EZ	BBG00TTG2T76
FPH1EUR:XS	BBG00TTG2TC0
FPH1EUR:X2	BBG00TTG2TD9
FPH1EUR:XH	BBG00TTG2TG6
FPH1EUR:XF	BBG00TTG2TJ3
FPH1EUR:XE	BBG00TTG2TL0
FPH1EUR:XJ	BBG00TTG2TM9
FPH1EUR:XL	BBG00TTG2TN8
FPH1EUR:XG	BBG00TTG2TR4
FPH1EUR:XO	BBG00TTG2TS3
FPH1EUR:XA	BBG00TTG2TY6
FPH1EUR:E1	BBG00TTG2TZ5
FPH1EUR:XT	BBG00TTG2V08
FPH1EUR:XW	BBG00TTG2V17
FPH1EUR:XU	BBG00TTG2V26
FPH1EUR:XV	BBG00TTG2V44
FPH1EUR:XM	BBG00TTG2V53
FPH1EUR:XQ	BBG00TTG2V62
FPH1EUR:XX	BBG00TTG2V71
FPH1EUR:XZ	BBG00TTG2V80
FPH1EUR:X1	BBG00TTG2VB6
FPH1EUR:EU	BBG00TTG2VP1

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodasFPH.NZ

ISINNZFAPE0001S2

VVP881319

Fisher & Paykel Healthcare Corporation akcijų apyvarta, EBIT, pelnas NZFAPE0001S2 · 881319

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Fisher & Paykel Healthcare Corporation Pajamų, pelno ir EBIT istorija.

Fisher & Paykel Healthcare Corporation Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Fisher & Paykel Healthcare Corporation Akcijos Maržos NZFAPE0001S2 · 881319

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Fisher & Paykel Healthcare Corporation Maržų istorija

Fisher & Paykel Healthcare Corporation akcijos apyvarta, EBIT, pelnas vienai akcijai NZFAPE0001S2 · 881319

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Fisher & Paykel Healthcare Corporation Pardavimų, pelno ir EBIT istorija vienai akcijai

Fisher & Paykel Healthcare Corporation akcija ir akcijų analizė

Fisher & Paykel Healthcare Corporation įvertinimas pagal istorinį P/E, EBIT ir P/S

Fisher & Paykel Healthcare Corporation akcijų skaičius NZFAPE0001S2 · 881319

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Fisher & Paykel Healthcare Corporation Akcijų padalijimai

Fisher & Paykel Healthcare Corporation akcijos dividendas NZFAPE0001S2 · 881319

Dividendas

Dividendų apžvalga

Interpretacija ir naudojimas

Investavimo strategija

Fisher & Paykel Healthcare Corporation Dividendų istorija

Fisher & Paykel Healthcare Corporation akcijų išmokėjimo koeficientas NZFAPE0001S2 · 881319

Dividendų mokėjimo rodiklis

Kas yra metinis dividendų mokėjimo rodiklis?

Kaip interpretuoti duomenis

Duomenų naudojimas investavimui

Fisher & Paykel Healthcare Corporation Dividendų išmokėjimo istorija

Fisher & Paykel Healthcare Corporation Pelno prognozės

Fisher & Paykel Healthcare Corporation Pelnų staigmenos

Eulerpool ESG reitingas Fisher & Paykel Healthcare Corporation akcijai

Eulerpool World ESG Rating (EESG©)

87/ 100

🌱 Environment

👫 Social

🏛️ Governance

Aplinka (Environment)

Socialinis (Social)

Įmonės valdymas (Governance)

Fisher & Paykel Healthcare Corporation akcijos akcininkų struktūra

Fisher & Paykel Healthcare Corporation Valdyba ir Priežiūros taryba

Dažnai užduodami klausimai apie Fisher & Paykel Healthcare Corporation akciją

What values and corporate philosophy does Fisher & Paykel Healthcare Corporation represent?

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
FPH.NZ

ISIN
NZFAPE0001S2

VVP
881319